India's Wockhardt gains after seeking regulatory nod for fast-acting insulin injection

Wockhardt

16/10/2024 06:00

** Shares of Wockhardt Ltd  WCKH.NS  rise as much as 4.3% to
1,126.50 rupees 
    ** Pharma co says it has filed fast-acting insulin analog,
Aspart injection, ASPARAPID with the Drugs Controller General of
India for regulatory approval of licences 
    ** Stock on track to gain for 4th straight day
    ** More than 338,000 shares traded as of 10:19 a.m. IST, vs
their 30-day moving avg of 253,517 shares
    ** WCKH last up 1.8%, adding to YTD gains of ~159% so far

 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com;))